| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.1929 | 42 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.012 | 27 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.3179 | 29 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.6635 | 21 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.8483 | 48 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.4278 | 15 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.036 | 18 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.3 | 19 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.3485 | 29 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.2553 | 28 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.5142 | 30 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.4425 | 29 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.8204 | 59 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.1576 | 18 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.493 | 15 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.5351 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.6658 | 25 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.5414 | 30 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.7895 | 48 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.7096 | 16 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.845 | 36 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.041 | 18 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.6297 | 12 |